Board of Directors

Page Header Image

Eckhard Alt, MD, PhD
Executive Chairman of InGeneron, Inc.

Eckhard U. Alt is professor of medicine and biomedical engineering at Tulane University in New Orleans and was professor of medicine at University of Texas MD Anderson Cancer Center in Houston and at Technical University of Munich. He received his medical degree as valedictorian from Heidelberg Medical School. After two years in cardiac surgery at the Ludwig-Maximilians-University Munich, he completed his education at Technical University of Munich in internal medicine/cardiology.

Eckhard is a frequent reviewer and serves on the editorial boards of respected journals. From 2001 to 2007, he was president of the Cardiac Electrophysiology Society. He has organized major national and international congresses; authored more than 500 publications in peer-reviewed journals, books, or book chapters; and has acquired more than 600 worldwide patents, primarily in the fields of stem cells, electrophysiology, and interventional cardiology. The magazine Focus rated him among the “Best 12 Cardiologists in Germany.” Eckhard received the Hahn Research Award from the European Society of Thoracic Surgeons as well as the Ethica Award as Best Experimental Researcher from Erasmus University in Rotterdam. In 2009, he was named Entrepreneur of the Year in Munich and Innovator of the Year in Houston. In addition to being Executive Chairman of InGeneron, Inc., he is also chairman of the board of ISAR Klinikum in Munich, Germany.


Kent Lehr

Kent Lehr is chief business development officer at Sanford Health and oversees Sanford Health’s business development strategy, growth initiatives, innovative partnerships, and commercialization efforts. Lehr joined Sanford Health in 2020 after a decade-long career with UnityPoint Health, where he started as an administrative fellow before holding several leadership positions in strategic growth and business development. He most recently served as UnityPoint Health’s vice president of strategy and business development.

A native of Des Moines, Iowa, Lehr holds a bachelor’s degree in biochemistry and molecular biology from Cornell College (Iowa) and a Master of Business Administration and Master of Health Administration from the University of Iowa.

Amber Langner, CPA, CHFP

Amber Langner is VP Treasury for Sanford Health and has significant financial experience in the Healthcare Industry. She offers a wealth of knowledge in financial planning, forecast analysis, financial systems strategy implementation, and accounting. Amber spent 5 years at Sanford leading innovative changes to the accounting and finance department and she continues to push for efficiency and innovation in her new role as VP Treasury.


Bobby I. Griffin, PhD

Bobby I. Griffin retired from a 25-year career with Medtronic, Inc., where he held various executive-level positions, including president of Medtronic’s CRM Business from 1991 to 1998. He manages his own fund of companies and serves on the advisory boards of Affinity Capital Management Fund III and IV and Sapient Capital Management Fund, in which he also invests. In addition, Bobby has served on the board of directors of several public companies, including MTS Systems Corporation and Urologix, Inc., and is currently a director of several private companies.


Jerry C. Griffin, MD

Jerry C. Griffin is president of Griffin & Schwartz, Scientific Services Inc., a management consulting firm in the health care products field. He has assisted several development stage companies in areas ranging from venture and public financing to FDA and clinical trial strategy. He is currently a member of the boards of directors of a number of private companies. During his academic tenure, Jerry held leadership positions in several national and international cardiology organizations and is the author or coauthor of five books, four patents, and over 170 medical and scientific articles.


Klaus L. Keller

Klaus L. Keller is founding chairman, CEO, and majority shareholder of Sueba USA Corporation in Houston, Texas. He is active in the areas of acquisition, development, and management of U.S. real estate and real estate investment funds. Klaus is also a private investor and syndicator.